AstraZeneca snaps up Fusion Pharmaceuticals Inc for over $2 billion

Another week, another takeover deal from AstraZeneca.

Last week AstraZeneca bought Amolyt Pharma for over $1 billion and today the FTSE 100-listed giant is paying over $2 billion for Fusion Pharmaceutical, a US-listed biopharmaceutical company...


Register for free to see rest of this article and all public articles from Betaville

Login / Register
Date: Tuesday, 19 March 2024, 9:50 am

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Login to join the conversation